Literature DB >> 20680277

Rapamycin suppresses ROS-dependent apoptosis caused by selenomethionine in A549 lung carcinoma cells.

Maiko Suzuki1, Manabu Endo, Fumiaki Shinohara, Seishi Echigo, Hidemi Rikiishi.   

Abstract

PURPOSE: Although selenium compounds possess chemotherapeutic features by inducing apoptosis in cancer cells with trivial side effects on normal cells, the mechanisms underlying its anti-cancer activity are insufficiently understood at the present. In this study, we investigated the effects of rapamycin on apoptosis induced by seleno-L-methionine (SeMet) or selenite in A549 cells.
METHODS: The effects of Se compounds, SeMet and selenite, on cell proliferation, apoptosis and its signaling pathway were investigated in established human adenocarcinoma cell line (A549). Cancer cells were treated with each Se during different periods. Cell apoptosis and signaling molecules were analyzed by flow cytometry (TUNEL method) or immunoblotting, respectively.
RESULTS: SeMet induces reactive oxygen species generation associated with the induction of apoptosis, because pretreatment of cells with N-acetyl-L-cysteine completely blocked SeMet-induced apoptosis. We also found that rapamycin completely suppressed the apoptosis of cells treated by SeMet, but not selenite. SeMet-induced apoptosis is significantly downregulated in combination with PI3 K family inhibitors (LY294002, wortmannin, PI-103, and 3-methyladenine). In addition, ROS generation was included in downstream signaling events associated with the phosphorylation of mTOR, because pretreatment of cells with rapamycin inhibited ROS generation.
CONCLUSION: These results suggest that SeMet-induced apoptosis is affected by the Akt/mTOR/ROS pathway in A549 cells. Akt serves an anti-survival function in the system of SeMet-treated lung cancer cells, but autophagic signaling remained unsolved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20680277     DOI: 10.1007/s00280-010-1417-7

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  9 in total

1.  Combined Acylselenourea-Diselenide Structures: New Potent and Selective Antitumoral Agents as Autophagy Activators.

Authors:  Pablo Garnica; Ignacio Encío; Daniel Plano; Juan A Palop; Carmen Sanmartín
Journal:  ACS Med Chem Lett       Date:  2018-03-13       Impact factor: 4.345

2.  Neuroprotective effects of Hu-Yi-Neng, a diet supplement, on SH-SY5Y human neuroblastoma cells.

Authors:  Y-H Yang; T-J Hsieh; M-L Tsai; C-H Chen; H-T Lin; S-J Wu
Journal:  J Nutr Health Aging       Date:  2014       Impact factor: 4.075

Review 3.  Better Living through Chemistry: Caloric Restriction (CR) and CR Mimetics Alter Genome Function to Promote Increased Health and Lifespan.

Authors:  Zoe E Gillespie; Joshua Pickering; Christopher H Eskiw
Journal:  Front Genet       Date:  2016-08-18       Impact factor: 4.599

4.  Erzhi Pill® Repairs Experimental Liver Injury via TSC/mTOR Signaling Pathway Inhibiting Excessive Apoptosis.

Authors:  Bu-Gao Zhou; Hai-Mei Zhao; Xiu-Yun Lu; Xin Wang; Yong Zou; Rong Xu; Hai-Yang Yue; Yi Liu; Zheng-Yun Zuo; Duan-Yong Liu
Journal:  Evid Based Complement Alternat Med       Date:  2017-05-30       Impact factor: 2.629

5.  Whey Protein Concentrate Renders MDA-MB-231 Cells Sensitive to Rapamycin by Altering Cellular Redox State and Activating GSK3β/mTOR Signaling.

Authors:  Shih-Hsuan Cheng; Yang-Ming Tseng; Szu-Hsien Wu; Shih-Meng Tsai; Li-Yu Tsai
Journal:  Sci Rep       Date:  2017-11-21       Impact factor: 4.379

Review 6.  Selenium compounds, apoptosis and other types of cell death: an overview for cancer therapy.

Authors:  Carmen Sanmartín; Daniel Plano; Arun K Sharma; Juan Antonio Palop
Journal:  Int J Mol Sci       Date:  2012-08-02       Impact factor: 6.208

7.  Azithromycin synergistically enhances anti-proliferative activity of vincristine in cervical and gastric cancer cells.

Authors:  Xuezhang Zhou; Yuyan Zhang; Yong Li; Xiujing Hao; Xiaoming Liu; Yujiong Wang
Journal:  Cancers (Basel)       Date:  2012-12-04       Impact factor: 6.639

8.  Stable Isotope-Resolved Metabolomics Shows Metabolic Resistance to Anti-Cancer Selenite in 3D Spheroids versus 2D Cell Cultures.

Authors:  Teresa W-M Fan; Salim S El-Amouri; Jessica K A Macedo; Qing Jun Wang; Huan Song; Teresa Cassel; Andrew N Lane
Journal:  Metabolites       Date:  2018-07-10

9.  Novel N,N'-Disubstituted Selenoureas as Potential Antioxidant and Cytotoxic Agents.

Authors:  Gorka Calvo-Martín; Daniel Plano; Ignacio Encío; Carmen Sanmartín
Journal:  Antioxidants (Basel)       Date:  2021-05-14
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.